Philippe Fournier

Title: Philippe Fournier - Innovator in Cancer Therapy

Introduction

Philippe Fournier is a notable inventor based in Edingen, Germany. He has made significant contributions to the field of cancer therapy through his innovative research and development. His work focuses on utilizing advanced techniques to improve treatment outcomes for patients with solid tumors.

Latest Patents

Fournier holds a patent for a groundbreaking invention titled "Multi-modal cancer therapy using viral hitch-hiking." This invention involves an antibody fusion protein that specifically recognizes the VA, HN, or F surface antigen of the Newcastle Disease Virus (NDV). It also targets surface molecules of tumor-unspecific T cells or dendritic cells, along with an immunocytokine. The patent encompasses polynucleotides encoding the antibody fusion protein and describes a method for treating tumors by administering the antibody fusion protein, tumor-unspecific T cells, dendritic cells, or the polynucleotide. This innovative approach aims to enhance the effectiveness of cancer treatments.

Career Highlights

Throughout his career, Philippe Fournier has worked with esteemed organizations, including the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts and Schirrmacher, Dr. Volker. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Fournier has collaborated with notable colleagues such as Volker Schirrmacher and Maximilian Aigner. Their combined expertise has contributed to the advancement of cancer therapies and the development of innovative treatment methods.

Conclusion

Philippe Fournier's contributions to cancer therapy through his patent and collaborations highlight his commitment to improving patient outcomes. His innovative approaches continue to pave the way for advancements in the treatment of solid tumors.